| 000 | 01874cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030904.0 | ||
| 008 | 131116s2013 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.31.Ph.D.2013.Mo.H | ||
| 100 | 0 | _aMohamed Farouk Hussein Abdallah | |
| 245 | 1 | 0 |
_aHepatic malignancies role of drug eluting beads versus conventional TACE / _cMohamed Farouk Hussein Abdallah ; Supervised Mohamed Mostafa Hamed , Moataz Hassan Hassanein , Amr Abdelfattah Nassef |
| 246 | 1 | 5 | _aدراسة مقارنة ما بين دور الحقن الكيماوى عن طريق الصمات الشريانية و الحبيبات فى علاج اورام الكبد |
| 260 |
_aCairo : _bMohamed Farouk Hussein Abdallah , _c2013 |
||
| 300 |
_a168 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Radio-diagnosis | ||
| 520 | _aSuper -selective chemoembolization should be performed to avoid non-target organ injury after making certain that there is no reflux of the cytotoxic or embolic materials into the non -target artery thus decreasing the possibility of non-target organ complications during TACE. Reported non-target organ complications include ischemic cholecystitis, splenic infarction, gastrointestinal mucosal lesions, pulmonary embolism and infarction, spinal cord injury, and ischemic skin lesions | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aDEB | |
| 653 | 4 | _aHCC | |
| 653 | 4 | _aTACE | |
| 700 | 0 |
_aAmr Abdelfattah Nassef , _eSupervisor |
|
| 700 | 0 |
_aMoataz Hassan Hassanein , _eSupervisor |
|
| 700 | 0 |
_aMohamed Mostafa Hamed , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c44089 _d44089 |
||